Jenny Bergqvist1, Peter Strang2. 1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Surgery, Capio St Görans Sjukhus, Stockholm, Sweden. Electronic address: jenny.bergqvist@ki.se. 2. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Research and Development, Stockholms Sjukhem Foundation, Stockholm, Sweden.
Abstract
CONTEXT: Women with metastatic breast cancer often receive many lines of palliative chemotherapy, which might be beneficial but also harmful. Still, little is known about the patients' perception of the patient-doctor communication regarding late lines of noncurative treatment. OBJECTIVES: Our aim was to explore breast cancer patients' preferences and perceptions of patient-doctor communication regarding continuous late lines of palliative chemotherapy. PATIENTS AND METHODS: A qualitative study was conducted with semiguided face-to-face interviews with 20 women, 40-80 years old, on at least their second line of palliative chemotherapy (second to eighth line). We used a qualitative conventional content analysis. RESULTS: All women knew they had incurable breast cancer but expressed hope for cure. Patients' definition of a good compassionate doctor was one who gives positive news and leaves room for hope. Ongoing chemotherapy, positive news from the doctors, and support from relatives encouraged hope. The women often expressed they accepted chemotherapy to please their doctor and relatives. The informants appreciated the doctor to be honest, but within positive limits. Over time, they stopped asking questions afraid of getting bad news, and left more and more treatment decisions to the doctor. CONCLUSIONS: The women's preferences for truth versus hope in patient-doctor communication changed over time, which increase the risk for continuous late lines of palliative chemotherapy by common collusion. Doctors need to individualize information, help patients make sense of their life, and allow hope to endure without further chemotherapy.
CONTEXT: Women with metastatic breast cancer often receive many lines of palliative chemotherapy, which might be beneficial but also harmful. Still, little is known about the patients' perception of the patient-doctor communication regarding late lines of noncurative treatment. OBJECTIVES: Our aim was to explore breast cancerpatients' preferences and perceptions of patient-doctor communication regarding continuous late lines of palliative chemotherapy. PATIENTS AND METHODS: A qualitative study was conducted with semiguided face-to-face interviews with 20 women, 40-80 years old, on at least their second line of palliative chemotherapy (second to eighth line). We used a qualitative conventional content analysis. RESULTS: All women knew they had incurable breast cancer but expressed hope for cure. Patients' definition of a good compassionate doctor was one who gives positive news and leaves room for hope. Ongoing chemotherapy, positive news from the doctors, and support from relatives encouraged hope. The women often expressed they accepted chemotherapy to please their doctor and relatives. The informants appreciated the doctor to be honest, but within positive limits. Over time, they stopped asking questions afraid of getting bad news, and left more and more treatment decisions to the doctor. CONCLUSIONS: The women's preferences for truth versus hope in patient-doctor communication changed over time, which increase the risk for continuous late lines of palliative chemotherapy by common collusion. Doctors need to individualize information, help patients make sense of their life, and allow hope to endure without further chemotherapy.
Authors: Carlos Eduardo Paiva; Ana Clara Teixeira; Bruna Minto Lourenço; Daniel D'Almeida Preto; Talita Caroline de Oliveira Valentino; Mirella Mingardi; Bianca Sakamoto Ribeiro Paiva Journal: Int J Environ Res Public Health Date: 2022-05-21 Impact factor: 4.614
Authors: Janine Westendorp; Andrea W M Evers; Jacqueline M L Stouthard; Janneke Budding; Elsken van der Wall; Nicole M F Plum; Mirjam Velting; Anneke L Francke; Sandra van Dulmen; Tim C Olde Hartman; Liesbeth M Van Vliet Journal: Cancer Date: 2021-11-11 Impact factor: 6.921
Authors: Naomi C A van der Velden; Hanneke W M van Laarhoven; Sjaak A Burgers; Lizza E L Hendriks; Filip Y F L de Vos; Anne-Marie C Dingemans; Joost Jansen; Jan-Maarten W van Haarst; Joyce Dits; Ellen Ma Smets; Inge Henselmans Journal: BMC Cancer Date: 2022-09-01 Impact factor: 4.638